Objectives: Underlying mechanisms regulating angiogenesis in ovarian cancer have not been completely elucidated. Evidence suggests that the TP53 tumor suppressor pathway and tumor microenvironment play integral roles. We utilized microarray technology to study the interaction between TP53 mutational status & hypoxia on angiogenic gene expression.Methods: Affymetrix U133A arrays were analyzed for angiogenic gene expression in 19 ovarian cancer cell lines stratified both by TP53 mutation status and A2780 wild-type (wt) TP53 vs. mutated (m) TP53 cell lines after treatment under hypoxic conditions or with ionizing radiation. Results: Twenty-eight differentially expressed angiogenic genes were identified in the mTP53 cell lines compared to wtTP5...
BACKGROUND: Colorectal cancer (CRC) is characterised by hypoxia, which activates gene transcription ...
Background: Human ovarian carcinoma is a silent killer. Most patients with human ovarian carcinoma a...
Oncogenes and tumor suppressor genes are implicated in the regulation of the angiogenic switch. Much...
Mutations of the p53 tumor suppressor gene are associated with large differences (>7 vessels/HPF) in...
OBJECTIVES: Forty percent of women with ovarian carcinoma have circulating free neoplastic DNA ident...
BACKGROUND: Targeting differentially activated or perturbed tumour pathways is the key idea in indiv...
Ovarian cancer is the most lethal gynecological disease affecting women in the US. The Cancer Genome...
International audienceThe tumour suppressor p53, involved in DNA repair, cell cycle arrest and apopt...
Background: We recently identified two robust ovarian cancer subtypes, defined by the expression of ...
Although the transition from early- to advanced-stage ovarian cancer is a critical determinant of su...
Anti-angiogenic therapies are an important class of anti-cancer treatment drugs. However, their effi...
Angiogenesis is a complex multicellular process requiring the orchestration of many events including...
The tumour suppressor p53, involved in DNA repair, cell cycle arrest and apoptosis, also inhibits bl...
Objective To identify key genes in ovarian cancer using transcriptome sequencing in two cell lines: ...
Ovarian cancer is the fifth leading cause of cancer death for women in the U.S. and the seventh most...
BACKGROUND: Colorectal cancer (CRC) is characterised by hypoxia, which activates gene transcription ...
Background: Human ovarian carcinoma is a silent killer. Most patients with human ovarian carcinoma a...
Oncogenes and tumor suppressor genes are implicated in the regulation of the angiogenic switch. Much...
Mutations of the p53 tumor suppressor gene are associated with large differences (>7 vessels/HPF) in...
OBJECTIVES: Forty percent of women with ovarian carcinoma have circulating free neoplastic DNA ident...
BACKGROUND: Targeting differentially activated or perturbed tumour pathways is the key idea in indiv...
Ovarian cancer is the most lethal gynecological disease affecting women in the US. The Cancer Genome...
International audienceThe tumour suppressor p53, involved in DNA repair, cell cycle arrest and apopt...
Background: We recently identified two robust ovarian cancer subtypes, defined by the expression of ...
Although the transition from early- to advanced-stage ovarian cancer is a critical determinant of su...
Anti-angiogenic therapies are an important class of anti-cancer treatment drugs. However, their effi...
Angiogenesis is a complex multicellular process requiring the orchestration of many events including...
The tumour suppressor p53, involved in DNA repair, cell cycle arrest and apoptosis, also inhibits bl...
Objective To identify key genes in ovarian cancer using transcriptome sequencing in two cell lines: ...
Ovarian cancer is the fifth leading cause of cancer death for women in the U.S. and the seventh most...
BACKGROUND: Colorectal cancer (CRC) is characterised by hypoxia, which activates gene transcription ...
Background: Human ovarian carcinoma is a silent killer. Most patients with human ovarian carcinoma a...
Oncogenes and tumor suppressor genes are implicated in the regulation of the angiogenic switch. Much...